Pyrimidine Compounds Selective Serotonin Receptor Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic agents targeting serotonin receptors often exhibit non-selectivity, leading to favorable therapeutic outcomes but also undesirable side effects due to their action on multiple receptor types, limiting their efficacy and safety.
Innovation Solution
Development of pyrimidine compounds that selectively modulate serotonin receptors, particularly the 5-HT7 and 5-HT2 subtypes, to treat diseases mediated by serotonin activity, which can be used alone or in combination with other therapeutic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-selective therapeutic agents are used to target serotonin receptors, then therapeutic outcomes are improved through multi-receptor action, but side effects increase due to action on multiple receptor types
Solution Approach 1:
The patent applies segmentation by designing compounds that selectively target specific serotonin receptor subtypes (5-HT1A, 5-HT1B, 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, 5-HT6, or 5-HT7) rather than acting on multiple receptor types simultaneously. This subdivision of therapeutic action allows for improved efficacy through targeted modulation while reducing off-target effects that cause side effects.
Solution Approach 2:
The patent employs local quality by creating compounds with specific molecular structures (pyrimidine, pyridine, indole, benzimidazole, or triazole rings with particular substituents) that confer selectivity for specific serotonin receptor subtypes. This localized molecular design ensures the compound interacts preferentially with its intended target receptor, improving therapeutic reliability while minimizing harmful interactions with other receptor types.
2Object-affected harmful factors
If selective ligands are developed to target specific serotonin receptors, then side effects are reduced, but the complexity of drug development increases
Solution Approach 1:
The patent applies parameter changes by systematically varying molecular parameters (ring structures, substituents, and their positions) to optimize receptor selectivity. By adjusting these chemical parameters, the invention achieves compounds with desired selectivity profiles for specific serotonin receptor subtypes, reducing side effects while managing development complexity through structured molecular optimization.
Data Source
AI summary
Certain pyrimidine-containing compounds are serotonin receptor modulators useful in the treatment of serotonin-mediated diseases.